About Causaly
Causaly is a company based in London (United Kingdom) founded in 2017. Causaly has raised $90.72 million across 5 funding rounds from investors including EBRD, Iconiq Capital and Index Ventures. The company has 62 employees as of December 31, 2023. Causaly offers products and services including AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG. Causaly operates in a competitive market with competitors including ScienceIO, Collaborative Drug Discovery, BioSymetrics, Citelighter and Qrativ, among others.
- Headquarter London, United Kingdom
- Employees 62 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Causaly Ltd
- Date of Incorporation 17 May, 2018
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$90.72 M (USD)
in 5 rounds
-
Latest Funding Round
$60 M (USD), Series B
Jul 13, 2023
-
Investors
EBRD
& 14 more
-
Employee Count
62
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Causaly
Causaly offers a comprehensive portfolio of products and services, including AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG.
Unified system for life sciences R&D using AI and knowledge graphs.
Tool for querying and analyzing biomedical data with citations.
High-precision graph for causal relationships in life sciences.
Platform to consolidate internal and external data for R&D.
System for accurate retrieval of life sciences information.
People of Causaly
Unlock access to complete
Funding Insights of Causaly
Causaly has successfully raised a total of $90.72M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $60 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Causaly
Causaly has secured backing from 15 investors, including venture fund and angel investors. Prominent investors backing the company include EBRD, Iconiq Capital and Index Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of investment management and real asset services
|
Locked | Locked | Locked | |
|
Venture capital investments in technology startups and entrepreneurs.
|
Locked | Locked | Locked | |
|
Venture capital funding is provided to early-stage startups.
|
Locked | Locked | Locked |
Investor details for Causaly
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Causaly
Investment portfolio details for Causaly
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Causaly
Detailed financials for Causaly
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Causaly Comparisons
Peer comparison for Causaly
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Causaly
Causaly operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ScienceIO, Collaborative Drug Discovery, BioSymetrics, Citelighter and Qrativ, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI solutions transforming medical text into enriched healthcare data
|
|
| Locked | Locked | Locked |
Biological and chemical data are managed securely in a database.
|
|
| Locked | Locked | Locked |
Provider of a cognitive computing-based biomedical intelligence platform
|
|
| Locked | Locked | Locked |
Digital writing solution for K-20 students
|
|
| Locked | Locked | Locked |
AI based drug purposing platform to identify treatments for rare diseases
|
Detailed competitors of Causaly
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Causaly
Complete news archive for Causaly
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Causaly
Causaly was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Causaly is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Causaly is a funded company, having raised a total of $90.72M across 5 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Causaly is 62.
Causaly was founded in 2017 and is headquartered in London, United Kingdom. The company operates in the biomedical AI sector, where software is developed to extract evidence from academic publications, clinical trials, regulatory documents, patents, and other sources. Hidden causal relationships in biomedical data are identified and curated through this technology, supporting researchers in cause-and-effect analysis.
Causaly's top competitors include ScienceIO, BioSymetrics and Collaborative Drug Discovery.
Causaly offers AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG.
Causaly has 15 investors. Key investors include EBRD, Iconiq Capital, Index Ventures, Marathon Venture Capital, and Pentech.